Trial Outcomes & Findings for Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard) (NCT NCT02759055)
NCT ID: NCT02759055
Last Updated: 2021-03-16
Results Overview
10-year cardiovascular risk was calculated at the index and all post-index patient encounters. A comparison of the difference in model-estimated annual rate of change in cardiovascular risk in Clinical Decision Support versus Usual Care clinics tested the primary efficacy hypothesis. The American College of Cardiology/American Heart Association (ACC/AHA) pooled CV risk calculator provides sex- and race-specific 10-year risk estimates for the first ASCVD event for black \& white men \& women aged 40-79 years. Variables included in risk assessment equations: age, total cholesterol, high-density lipoprotein cholesterol (HDL-C), systolic blood pressure (SBP) diabetes mellitus (diabetes), and current smoking status. 10-year risk for ASCVD categorized as: Low (\<5%), Borderline (5% to 7.4%), Intermediate (7.5% to 19.9%), High (≥20%). Numerator: Rate of change in Clinical Decision Support. Denominator: Rate of change in Usual Care. Relative Risk \< 1 supports primary hypothesis.
COMPLETED
NA
21664 participants
Index visit to 12 months post index visit
2021-03-16
Participant Flow
Participant milestones
| Measure |
Clinical Decision Support (CV Wizard)
In the Intervention arm, primary care providers will be provided with an Electronic Health Record-linked, Web-based clinical decision support system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke, optimizing management and follow up of pre-diabetes patients with uncontrolled cardiovascular risk factors.
Clinical Decision Support: an Electronic Health Record(EHR)-linked, Web-based clinical decision support(CDS) system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke
|
Usual Care
In the No Intervention arm, patients receive usual care from their primary care clinic and care providers.
|
|---|---|---|
|
Overall Study
STARTED
|
12702
|
8962
|
|
Overall Study
COMPLETED
|
10775
|
7454
|
|
Overall Study
NOT COMPLETED
|
1927
|
1508
|
Reasons for withdrawal
| Measure |
Clinical Decision Support (CV Wizard)
In the Intervention arm, primary care providers will be provided with an Electronic Health Record-linked, Web-based clinical decision support system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke, optimizing management and follow up of pre-diabetes patients with uncontrolled cardiovascular risk factors.
Clinical Decision Support: an Electronic Health Record(EHR)-linked, Web-based clinical decision support(CDS) system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke
|
Usual Care
In the No Intervention arm, patients receive usual care from their primary care clinic and care providers.
|
|---|---|---|
|
Overall Study
Patients with no follow-up visit and/or age 18-39 were not included in analyses.
|
1927
|
1508
|
Baseline Characteristics
Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)
Baseline characteristics by cohort
| Measure |
Clinical Decision Support (Cardiovascular Wizard)
n=10775 Participants
In the Intervention arm, primary care providers will be provided with an Electronic Health Record-linked, Web-based clinical decision support system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based Clinical Decision Support and follow up to reduce risk of heart attacks or stroke, optimizing management and follow up of pre-diabetes patients with uncontrolled cardiovascular risk factors.
Clinical Decision Support: an Electronic Health Record-linked, Web-based clinical decision support (CDS) system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke
|
Usual Care
n=7454 Participants
In the No Intervention arm, patients receive usual care from their primary care clinic and care providers.
|
Total
n=18229 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
6331 Participants
n=5 Participants
|
4713 Participants
n=7 Participants
|
11044 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
4444 Participants
n=5 Participants
|
2741 Participants
n=7 Participants
|
7185 Participants
n=5 Participants
|
|
Age, Continuous
|
61.2 years
STANDARD_DEVIATION 8.8 • n=5 Participants
|
60.5 years
STANDARD_DEVIATION 8.8 • n=7 Participants
|
60.9 years
STANDARD_DEVIATION 8.8 • n=5 Participants
|
|
Sex: Female, Male
Female
|
5428 Participants
n=5 Participants
|
3808 Participants
n=7 Participants
|
9236 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5347 Participants
n=5 Participants
|
3646 Participants
n=7 Participants
|
8993 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
49 Participants
n=5 Participants
|
30 Participants
n=7 Participants
|
79 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
10726 Participants
n=5 Participants
|
7424 Participants
n=7 Participants
|
18150 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
172 Participants
n=5 Participants
|
52 Participants
n=7 Participants
|
224 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
40 Participants
n=5 Participants
|
36 Participants
n=7 Participants
|
76 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
7 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
77 Participants
n=5 Participants
|
38 Participants
n=7 Participants
|
115 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10399 Participants
n=5 Participants
|
7299 Participants
n=7 Participants
|
17698 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
78 Participants
n=5 Participants
|
24 Participants
n=7 Participants
|
102 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
10775 participants
n=5 Participants
|
7454 participants
n=7 Participants
|
18229 participants
n=5 Participants
|
|
Cardiovascular Risk
|
11.2 units on a scale
STANDARD_DEVIATION 8.3 • n=5 Participants
|
11.1 units on a scale
STANDARD_DEVIATION 8.4 • n=7 Participants
|
11.2 units on a scale
STANDARD_DEVIATION 8.4 • n=5 Participants
|
PRIMARY outcome
Timeframe: Index visit to 12 months post index visitPopulation: The patients whose data were included in the primary outcome analysis were those who met eligibility criteria in the eligibility table.
10-year cardiovascular risk was calculated at the index and all post-index patient encounters. A comparison of the difference in model-estimated annual rate of change in cardiovascular risk in Clinical Decision Support versus Usual Care clinics tested the primary efficacy hypothesis. The American College of Cardiology/American Heart Association (ACC/AHA) pooled CV risk calculator provides sex- and race-specific 10-year risk estimates for the first ASCVD event for black \& white men \& women aged 40-79 years. Variables included in risk assessment equations: age, total cholesterol, high-density lipoprotein cholesterol (HDL-C), systolic blood pressure (SBP) diabetes mellitus (diabetes), and current smoking status. 10-year risk for ASCVD categorized as: Low (\<5%), Borderline (5% to 7.4%), Intermediate (7.5% to 19.9%), High (≥20%). Numerator: Rate of change in Clinical Decision Support. Denominator: Rate of change in Usual Care. Relative Risk \< 1 supports primary hypothesis.
Outcome measures
| Measure |
Clinical Decision Support (CV Wizard)
n=10775 Participants
In the Intervention arm, primary care providers will be provided with an Electronic Health Record-linked, Web-based clinical decision support system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based Clinical Decision Support and follow up to reduce risk of heart attacks or stroke, optimizing management and follow up of pre-diabetes patients with uncontrolled cardiovascular risk factors.
Clinical Decision Support: an EHR-linked, Web-based clinical decision support (CDS) system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke
|
Usual Care
n=7454 Participants
In the No Intervention arm, patients receive usual care from their primary care clinic and care providers.
|
|---|---|---|
|
Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke
|
1.100 units on a scale
Interval 1.097 to 1.103
|
1.096 units on a scale
Interval 1.029 to 1.101
|
Adverse Events
Clinical Decision Support (Cardiovascular Wizard)
Usual Care
Serious adverse events
| Measure |
Clinical Decision Support (Cardiovascular Wizard)
n=10775 participants at risk
In the Intervention arm, primary care providers will be provided with an EHR-linked, Web-based clinical decision support system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke, optimizing management and follow up of pre-diabetes patients with uncontrolled cardiovascular risk factors.
Clinical Decision Support: an EHR-linked, Web-based clinical decision support (CDS) system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke
|
Usual Care
n=7454 participants at risk
In the No Intervention arm, patients receive usual care from their primary care clinic and care providers.
|
|---|---|---|
|
General disorders
Hospitalizations
|
17.0%
1836/10775 • Up to 30 months
|
18.2%
1360/7454 • Up to 30 months
|
Other adverse events
| Measure |
Clinical Decision Support (Cardiovascular Wizard)
n=10775 participants at risk
In the Intervention arm, primary care providers will be provided with an EHR-linked, Web-based clinical decision support system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke, optimizing management and follow up of pre-diabetes patients with uncontrolled cardiovascular risk factors.
Clinical Decision Support: an EHR-linked, Web-based clinical decision support (CDS) system that identifies patients with prediabetes and provides patients and their primary care providers personalized, evidence-based CDS and follow up to reduce risk of heart attacks or stroke
|
Usual Care
n=7454 participants at risk
In the No Intervention arm, patients receive usual care from their primary care clinic and care providers.
|
|---|---|---|
|
Metabolism and nutrition disorders
Serum Potassium <= 3.0 mg/dl
|
1.3%
138/10775 • Up to 30 months
|
1.3%
97/7454 • Up to 30 months
|
|
Metabolism and nutrition disorders
Serum Potassium >= 6.5 mg/dl †
|
0.03%
3/10775 • Up to 30 months
|
0.04%
3/7454 • Up to 30 months
|
|
Musculoskeletal and connective tissue disorders
Serum Total CK >= 1200 mg/dl †
|
0.16%
17/10775 • Up to 30 months
|
0.11%
8/7454 • Up to 30 months
|
|
Vascular disorders
SBP < 90 mm Hg †
|
1.4%
154/10775 • Up to 30 months
|
1.6%
121/7454 • Up to 30 months
|
|
Vascular disorders
SBP >= 200 mm Hg †
|
0.37%
40/10775 • Up to 30 months
|
0.48%
36/7454 • Up to 30 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place